Clinical Trials · NCT01973842
Evaluation of the Optimal Dose of GnRH Agonist for Triggering Final Oocyte Maturation in High Risk OHSS Patients
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- Aristotle University Of Thessaloniki
- Enrollment
- 90
- Start date
- Feb 2014
- Locations
- 2 sites, Greece
- Primary endpoint
- Percentage of mature oocytes retrieved